Skinbiotherapeutics (SBTX)

Company name:	Skinbiotherapeutics Plc
Company Description:	SkinBioTherapeutics is a life science company focused on skin health.
EPIC:	SBTX	Trading Currency:	GBX
Market Sector:	AMQ1	ISIN:	GB00BF33H870
Market Segment:	ASQ1	Share Type:	DE
WWW Address:	http://www.skinbiotherapeutics.com/	Description:	ORD 1P
Industry Sector:	PHARMACEUTICALS & BIOTECHNOLOGY

Skinbiotherapeutics Key Figures

(at previous day's close)
Market Cap.	94.31	m
Shares In Issue	155.89	m
Prev. Close	59.00
PE Ratio	-
Dividend Yield	-	%
EPS - basic	-1.17	p
Dividend PS	-	p
Dividend Cover	-
Cash Flow PS	-0.57	p
Return On Equity (ROE)	-60.83	%
Operating Margin	-	%
PEG Factor	-
EPS Growth Rate	-24.47	%
Dividends PS Growth Rate	-	%
Net Debt	-1.85	m
Gross Gearing	11.00	%
Quick Assets	2.35	m
Net Working Capital	2.04	m
Intangibles / Fixed Assets	99.60	%
Turnover PS	-	p
Pre-Tax Profit PS	-1.04	p
Retained Profit PS	-0.10	p
Cash PS	1.38	p
Net Cash PS	1.19	p
Net Tangible Asset Value PS *	1.31	p
Net Asset Value PS	1.58	p
Spread	1.00 (1.64%)
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Period ^†	Open	Change	%	Open Avg.	Avg. Daily Vol [m]	Total Vol [m]	VWAP
1 week	46.00	14.50	31.52	46.00	1.12		55.53
4 weeks	42.25	18.25	43.20	42.25	1.33		50.37
12 weeks	29.75	30.75	103.36	29.00	1.37		41.99
26 weeks	19.50	41.00	210.26	7.58	1.17		34.01
1 year	7.00	53.50	764.29	7.00	0.95		27.80
3 years	9.25	51.25	554.05	5.75	0.56		22.90
5 years	13.25	47.25	356.60	5.75	0.50		21.08
† periods calculated are whole weeks rather than calendar months

(Market value analysis) at previous day's close
PQ Ratio	-
PE Ratio	-
Tobin's Q Ratio	28.14
Tobin's Q Ratio (excl. intangibles)	31.78
Dividend Yield	-	%
Market-to-Book Ratio	38.25
Price-to-Pre-Tax Profit PS	-58.22
Price-to-Retained Profit PS	-628.40
Price-to-Cash Flow PS	-105.72
Price-to-Sales PS	-
Price-to-Net Tangible Asset Value PS	46.11
Price-to-Cash PS	43.68
Net Working Capital PS	1.31
Price Pct to Working Capital PS	46.15	%
Earnings Yield	-	%
Average PE	-
Years in average	-
PE to PE average	-	%

(Leverage Ratios)
Debt Ratio	-	%
Debt-to-Equity Ratio	-
Debt-to-Equity Ratio (excl. Intgbl)	-
Debt-to-Equity Market Value	-
Net Gearing	-66.92	%
Net Gearing (excl. Intangibles)	-78.90	%
Gross Gearing	11.00	%
Gross Gearing (excl. Intangibles)	12.97	%
Gearing Under 1 Year	11.00	%
Gearing Under 1 Year (excl. Intgbl)	12.97	%
Assets/Equity	1.12
Cash/Equity	87.56
(Liquidity Ratios)
Net Working Capital to Total Assets	73.76	%
Current Ratio	7.70
Quick Ratio (Acid Test)	7.70
Liquidity Ratio	7.08
Cash & Equiv/Current Assets	91.94	%
(Solvency Ratios)
Enterprise Value	92.15	m
CFO/Sales	-
CFO/Attributable Profit	-
CFO/Assets	-0.32
CFO/Debt	-2.93
Total Debt/Equity Market Value	0.00
Total Debt/Sales	-
Total Debt/Pre-Tax Profit	-0.19
Total Debt	0.30	m
Total Debt/Net Current Assets	0.15	%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth	-	%
5 yr Compound Earnings Growth	-	%
10 yr Compound Earnings Growth	-	%
Earn drops > 5% in 10yrs	2

Beta (60-Mnth)	Beta (36-Mnth)
-0.0027	0.0017

(Profitability Ratios)
Return On Capital Employed (ROCE)	-65.70	%
Return On Assets (ROA)	-44.76	%
Net Profit Margin	-	%
Assets Turnover	-
Return On Equity (ROE)	-60.83	%
Return On Investment (ROI)	-47.80	%
Dividend Payout Ratio	-	%
Plowback Ratio	100.00	%
Growth from Plowback Ratio	-	%
Net Income Of Revenues	-	%
(Asset Utilisation Multiples)
Shareholders Equity Turnover	-
Fixed Assets Turnover	-
Current Assets Turnover	-
Net Working Capital Turnover
Inventory Turnover	-
(Other Operating Ratios)
Total Assets-to-Sales	-
Debtors-to-Sales	-	%
Debt Collection Period	-	Days

Sorry No Data Available

Broker infomation is not available for this class of stock.